Helene Guermouche Selected Research

T-Cell Lymphoma (Lymphoma, T Cell)

12/2017

Response to 5-azacytidine in a patient with TET2-mutated angioimmunoblastic T-cell lymphoma and chronic myelomonocytic leukaemia preceded by an EBV-positive large B-cell lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Helene Guermouche Research Topics

Disease

1	Neoplasms (Cancer) 01/2023
1	Oncogene Addiction 01/2022
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 12/2017
1	T-Cell Lymphoma (Lymphoma, T Cell) 12/2017

Drug/Important Bio-Agent (IBA)

1	Proteins (Proteins, Gene)FDA Link 01/2023
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022
1	trametinibIBA 01/2022
1	Azacitidine (5 Azacytidine)FDA Link 12/2017

Therapy/Procedure

1	Therapeutics 01/2022